Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01842711 · ClinicalTrials.gov registry record
Cumulative Irritation Patch Test
A clinical trial, sponsored by Chattem.
- Completed
- Registry status
- 224
- Enrollment target
NCT01842711: Completed study, sponsored by Chattem.
NCT01842711 is a clinical trial that has completed, run by Chattem. The registered enrollment target is 224 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01842711 has completed, sponsored by Chattem.
- COMPLETED
- Registry status
- 224 participants
- Enrollment target
Study Summary
A Cumulative Patch Test with a Challenge Phase is a test devised to ascertain if a chemical agent or agents have the potential to cause contact irritation or contact allergy in the skin. Allergy is only elicited in immunologically competent individuals who have become sensitized through exposure to the chemical agent at a sufficient concentration and for a sufficient duration of time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2012-09 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842711
The ClinicalTrials.gov registry entry for NCT01842711 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chattem, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01842711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01842711 about?
NCT01842711 is a clinical study titled "Cumulative Irritation Patch Test". A Cumulative Patch Test with a Challenge Phase is a test devised to ascertain if a chemical agent or agents have the potential to cause contact irritation or contact allergy in the skin. Allergy is only elicited in immunologically competent individuals who have become sensitized through exposure to ...
What is the current status of trial NCT01842711?
This trial is currently completed. The enrollment target is 224 participants. The study started on 2012-09. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01842711?
This trial is sponsored by Chattem, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.